Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,542,342
+$470,998 QoQ
Shares Held
22,603
+12.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#325
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Snowden Capital Advisors LLC holds $146,228,358 across 13 Drug Manufacturers - General names. NVS ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,065 | $32,462,575 | |
| 2 | ABBV |
AbbVie Inc.
|
120,256 | $30,261,219 | |
| 3 | JNJ |
Johnson & Johnson
|
109,396 | $27,783,302 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,291 | $18,669,893 | |
| 5 | AMGN |
Amgen Inc
|
39,480 | $14,296,497 | |
| 6 | AZN |
Astrazeneca PLC
|
42,309 | $8,022,632 | |
| 7 | NVS |
Novartis AG
This page
|
22,603 | $3,542,342 | |
| 8 | PFE |
Pfizer Inc
|
125,051 | $3,011,228 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,542,342 | 22,603 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,071,344 | 20,107 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,703,521 | 12,356 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,566,964 | 12,219 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,509,962 | 12,478 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,276,000 | 11,446 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,274,663 | 13,099 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,590,956 | 13,832 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,740,088 | 16,345 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,501,636 | 15,524 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,520,810 | 15,062 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,417,789 | 13,919 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,543,014 | 15,291 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,505,212 | 16,361 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,530,718 | 16,873 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,337,623 | 17,598 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,852,644 | 21,917 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,076,954 | 23,669 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $294,074 | 3,362 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,251,403 | 27,530 | Shares | Sole | 2024-02-06 | |
| 2021-06-30 | $2,472,786 | 27,102 | Shares | Sole | 2024-01-08 | |
| 2021-03-31 | $1,068,841 | 12,504 | Shares | Sole | 2024-01-08 | |
| 2020-12-31 | $556,853 | 5,897 | Shares | Sole | 2024-01-08 | |
| 2020-09-30 | $262,880 | 3,023 | Shares | Sole | 2024-01-08 | |
| 2020-06-30 | $280,099 | 3,207 | Shares | Sole | 2024-01-08 | |
| 2020-03-31 | $274,805 | 3,333 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||